Axsome Therapeutics, Inc. (LON:0HKF)
London · Delayed Price · Currency is GBP · Price in USD 104.03
+1.36 (1.33%)
At close: Aug 6, 2025
Arcadium Lithium Market Cap
Axsome Therapeutics has a market cap or net worth of 3.86 billion as of August 7, 2025. Its market cap has increased by 22.03% in one year.
Market Cap
3.86B
Enterprise Value
3.80B
Revenue
361.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
$104.03
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from 95.66M to 3.86B, an increase of 3,936.87%. That is a compound annual growth rate of 46.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 3.86B | 17.91% |
| Dec 31, 2024 | 3.28B | 10.77% |
| Dec 29, 2023 | 2.96B | 6.36% |
| Dec 30, 2022 | 2.78B | 164.34% |
| Dec 31, 2021 | 1.05B | -52.81% |
| Dec 31, 2020 | 2.23B | -22.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.41B |
| GSK plc | 56.36B |
| Haleon | 31.43B |
| Smith & Nephew | 11.70B |
| ConvaTec Group | 4.61B |
| Hikma Pharmaceuticals | 4.22B |
| HUTCHMED (China) | 2.32B |
| Oxford Nanopore Technologies | 2.09B |